1-year base period, labor hour (LH) type task order for the food and drug administration (FDA) and the office of the commissioner (OC) to procure correspondence analyst, public health program…

Active Awarded Last action

Contract number
75F40125F19017
Awardee
Awarding agency
Obligated
$2,750,334

Award facts

Contract value 100% obligated
$2,750,333.99 Current and potential, with all options
Completion date 71% complete
Current and potential, with all options
Set-aside
Competitive 8(a)
Competition
Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$61,660
Original award $2,811,994

About this award

The Food and Drug Administration issued a delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, on September 30, 2025, with a ceiling value of $2,750,333.99 under the Professional, Administrative, and Consulting Services (PACS) IDIQ for correspondence analyst, public health program specialist, and management and program analyst services to the Office of the Commissioner.

The order is competitive 8(a) set-aside and covers a one-year base period under a labor-hour pricing model, with ultimate completion on March 29, 2027. Place of performance is Silver Spring, Maryland. The PACS IDIQ, a $100 million competitive 8(a) single-award vehicle, runs through August 2028 and supports professional, administrative, and consulting services across FDA. Kaiva Strategies operates as a managed service delivery vehicle; across SCI-reportable prime contracts, subcontractors performed approximately 70 percent of contractor hours with a median government-paid rate around $113.91 per hour.

Description

1-year base period, labor hour (LH) type task order for the food and drug administration (FDA) and the office of the commissioner (OC) to procure correspondence analyst, public health program specialist, and management and program analyst services.

Quick answers

Who was awarded contract 75F40125F19017?

75F40125F19017 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on September 30, 2025.

How much is contract 75F40125F19017 worth?

The government has obligated $2,750,334 on 75F40125F19017.

Is contract 75F40125F19017 an order under another contract?

Yes. 75F40125F19017 is a delivery order under 75F40123D00021, an indefinite delivery contract.

Was contract 75F40125F19017 competed?

The extent of competition for 75F40125F19017 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award